ABC of Clinical Trials with the Mark of Safety, Efficacy and Transparency

E-ISSN： 2213-4778|4|2|120-127

ISSN： 2213-476x

Source： Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol.4, Iss.2, 2017-08, pp. : 120-127

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of Calcipotriene 0.005% Foam for the Treatment of Plaque-Type Psoriasis: Results of Two Multicenter, Randomized, Double-Blind, Vehicle-Controlled, Phase III Clinical Trials

By Feldman Steven R.

American Journal of Clinical Dermatology, Vol. 13, Iss. 4, 2012-08 ,pp. : 261-271

Adis International

Access to resources Recommend Favorite

The Long-Term Safety of Adalimumab Treatment in Moderate to Severe Psoriasis: A Comprehensive Analysis of All Adalimumab Exposure in All Clinical Trials

By Leonardi Craig

American Journal of Clinical Dermatology, Vol. 12, Iss. 5, 2011-10 ,pp. : 321-337

Adis International

Access to resources Recommend Favorite

Modelling and Clinical Trials in Paediatrics

By Jacqmin Philippe

Therapie, Vol. 60, Iss. 4, 2005-01 ,pp. : 385-390

Adis International

Access to resources Recommend Favorite

Methodology for Small Clinical Trials

By Vray Muriel

Therapie, Vol. 59, Iss. 3, 2004-01 ,pp. : 281-286

Adis International

Access to resources Recommend Favorite

Transparency in Clinical Research and Status in Turkey Middle East

Applied Clinical Research, Clinical Trials and Regulatory Affairs, Vol. 2, Iss. 2, 2015-12 ,pp. : 80-82

Bentham Science Publishers

Access to resources Recommend Favorite